N/A
Completed N=30
Implementing PTSD Treatment in FQHCs for Michigan Medicaid Enrollees
Source: ClinicalTrials.gov NCT03711266 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Feb 2022
Primary outcomePrimary: Change in PTSD Symptoms (as Measured by the PCL-5) — 31.4 score on a scale — p=<.001
Summary
The purpose of this project is to expand access to trauma-focused treatment among Medicaid Enrollees with PTSD, thereby improving the quality of mental health services delivered to this population. Specifically, the project goals are to evaluate the delivery and sustainability of a brief trauma-focused treatment, Prolonged Exposure for Primary Care (PE-PC), an evidence-based intervention for PTSD, when delivered via telehealth to patients enrolled at CHCs in Michigan.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in PTSD Symptoms (as Measured by the PCL-5) |
31.4 | <.001 sig |
| SECONDARY Change in Depressive Symptoms (as Measured by the PHQ-9) |
8.5 | — |
| SECONDARY Change in Recovery Goals (Measured by the Recovery Assessment Scale; RAS) |
9.57 | — |
| SECONDARY Change in Posttraumatic Cognitions (Measured by the Post-Traumatic Cognitions Inventory; PTCI) |
2.65 | — |
Eligibility Criteria
Inclusion Criteria
- receive care at a Michigan CHC
- have a PCL-5 score ≥33
- have had psychotropic medication stability for at least 4 weeks
Exclusion Criteria
- substantially cognitively impaired (according to the Mini-Cog)
- unable to agree to study procedures for any reason (including incompetency)
- at high risk of suicide
- currently engaged in a trauma-focused behavioral treatment (such as Prolonged Exposure or Cognitive Processing Therapy)
- unable to speak English
Data sourced from ClinicalTrials.gov (NCT03711266). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.